AKYNZEO
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
69639-101 -
Package NDC
69639-101-01 -
Package NDC
69639-101-04 -
Application number
NDA205718 -
SPL ID
c1a46993-d1bf-4f84-8fac-e9c04a7d6bf1 -
SPL set ID
8e47618e-af46-4d82-94e8-1507c042252d -
UNII
23310D4I19 -
UNII
5D06587D6R -
UNII
T672P80L2S -
UNII
7732P08TIR -
RxCUI
1552343 -
RxCUI
1552349 -
RxCUI
2044429 -
RxCUI
2044431 -
RxCUI
2374366 -
RxCUI
2374368
What the source publishes
- Labeler
- Helsinn Therapeutics (U.S.), Inc.
- Active ingredients
- Netupitant and Palonosetron
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "AKYNZEO",
"splId": "c1a46993-d1bf-4f84-8fac-e9c04a7d6bf1",
"labels": [
{
"setId": "8e47618e-af46-4d82-94e8-1507c042252d",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8e47618e-af46-4d82-94e8-1507c042252d",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8e47618e-af46-4d82-94e8-1507c042252d"
}
],
"routes": [
"ORAL"
],
"labeler": "Helsinn Therapeutics (U.S.), Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 BLISTER PACK in 1 CARTON (69639-101-01) / 1 CAPSULE in 1 BLISTER PACK",
"package_ndc": "69639-101-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20141013"
},
{
"sample": false,
"description": "2 BLISTER PACK in 1 CARTON (69639-101-04) / 2 CAPSULE in 1 BLISTER PACK",
"package_ndc": "69639-101-04",
"identifierStatus": "well-formed",
"marketing_start_date": "20141013"
}
],
"productId": "69639-101_c1a46993-d1bf-4f84-8fac-e9c04a7d6bf1",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "69639-101",
"deaSchedule": null,
"genericName": "Netupitant and Palonosetron",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "NETUPITANT",
"strength": "300 mg/1"
},
{
"name": "PALONOSETRON",
"strength": ".5 mg/1"
}
],
"applicationNumber": "NDA205718",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20141013",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175817",
"N0000175818",
"N0000010262",
"N0000175786",
"N0000182141",
"N0000185503",
"N0000190113"
],
"upc": [
"0369639101046"
],
"unii": [
"23310D4I19",
"5D06587D6R",
"T672P80L2S",
"7732P08TIR"
],
"rxcui": [
"1552343",
"1552349",
"2044429",
"2044431",
"2374366",
"2374368"
],
"spl_set_id": [
"8e47618e-af46-4d82-94e8-1507c042252d"
],
"pharm_class_epc": [
"Serotonin-3 Receptor Antagonist [EPC]",
"Substance P/Neurokinin-1 Receptor Antagonist [EPC]"
],
"pharm_class_moa": [
"Serotonin 3 Receptor Antagonists [MoA]",
"Neurokinin 1 Antagonists [MoA]",
"Cytochrome P450 3A4 Inhibitors [MoA]",
"P-Glycoprotein Inhibitors [MoA]",
"Breast Cancer Resistance Protein Inhibitors [MoA]"
],
"manufacturer_name": [
"Helsinn Therapeutics (U.S.), Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:69639-101_c1a46993-d1bf-4f84-8fac-e9c04a7d6bf1"